Total Payments
$3,024
2024 Payments
$595.14
Companies
24
Transactions
173
Medicare Patients
864
Medicare Billing
$83,415
Payment Breakdown by Category
Food & Beverage$3,012 (99.6%)
Education$11.90 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,012 | 172 | 99.6% |
| Education | $11.90 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $599.12 | 42 | $0 (2024) |
| Novo Nordisk Inc | $552.85 | 36 | $0 (2024) |
| Boston Scientific Corporation | $277.68 | 3 | $0 (2024) |
| Merck Sharp & Dohme LLC | $260.85 | 19 | $0 (2022) |
| Amgen Inc. | $213.68 | 13 | $0 (2024) |
| Lilly USA, LLC | $153.61 | 11 | $0 (2024) |
| Horizon Therapeutics plc | $124.99 | 1 | $0 (2023) |
| PFIZER INC. | $121.82 | 9 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $101.00 | 6 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $98.13 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $595.14 | 26 | Novo Nordisk Inc ($167.34) |
| 2023 | $461.48 | 20 | Horizon Therapeutics plc ($124.99) |
| 2022 | $442.96 | 25 | Novo Nordisk Inc ($111.79) |
| 2021 | $389.42 | 20 | BOSTON SCIENTIFIC CORPORATION ($120.30) |
| 2020 | $253.10 | 19 | AstraZeneca Pharmaceuticals LP ($137.07) |
| 2019 | $240.08 | 18 | AstraZeneca Pharmaceuticals LP ($71.01) |
| 2018 | $321.88 | 24 | AstraZeneca Pharmaceuticals LP ($84.58) |
| 2017 | $319.62 | 21 | Novo Nordisk Inc ($74.59) |
All Payment Transactions
173 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/17/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $121.52 | General |
| Category: General - Therapies_CRM | ||||||
| 08/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Diabetes | ||||||
| 08/13/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Endocrinology | ||||||
| 07/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/18/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $35.86 | General |
| Category: General - Therapies_CRM | ||||||
| 07/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Inflammation | ||||||
| 06/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Diabetes | ||||||
| 06/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: RESPIRATORY | ||||||
| 05/21/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: Oncology | ||||||
| 05/10/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Obesity | ||||||
| 05/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/23/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Respiratory | ||||||
| 04/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Inflammation | ||||||
| 04/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Diabetes | ||||||
| 03/07/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Diabetes | ||||||
| 02/20/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.06 | General |
| Category: Cardiovascular | ||||||
| 02/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 221 | 295 | $127,104 | $20,675 |
| 2022 | 5 | 199 | 325 | $149,773 | $23,169 |
| 2021 | 5 | 231 | 338 | $138,009 | $21,610 |
| 2020 | 7 | 213 | 380 | $82,995 | $17,960 |
Total Patients
864
Total Services
1,338
Medicare Billing
$83,415
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 134 | $75,360 | $10,906 | 14.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 30 | 30 | $17,262 | $4,266 | 24.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 21 | 23 | $12,914 | $2,081 | 16.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 32 | $12,802 | $1,458 | 11.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 14 | 14 | $3,920 | $1,000 | 25.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 17 | 17 | $1,814 | $577.49 | 31.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 41 | 45 | $3,032 | $385.80 | 12.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 71 | 165 | $92,822 | $14,479 | 15.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 41 | 51 | $28,662 | $4,391 | 15.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 62 | $24,813 | $3,583 | 14.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 12 | $1,236 | $404.28 | 32.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 35 | 35 | $2,240 | $311.61 | 13.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 77 | 154 | $75,724 | $10,654 | 14.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 56 | 77 | $41,340 | $8,557 | 20.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 46 | 54 | $13,772 | $1,165 | 8.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 11 | 11 | $4,007 | $711.57 | 17.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 41 | 42 | $3,166 | $521.95 | 16.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 79 | 199 | $41,591 | $8,170 | 19.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 54 | 76 | $23,104 | $4,127 | 17.9% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2020 | 16 | 37 | $9,324 | $3,023 | 32.4% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Office | 2020 | 13 | 13 | $5,736 | $1,934 | 33.7% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 14 | 16 | $2,048 | $370.75 | 18.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 20 | 22 | $1,056 | $285.24 | 27.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 17 | 17 | $136.00 | $50.04 | 36.8% |
About Dr. Uzma Chatha, M.D
Dr. Uzma Chatha, M.D is a Internal Medicine healthcare provider based in East Orange, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/13/2010. The National Provider Identifier (NPI) number assigned to this provider is 1407174451.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Uzma Chatha, M.D has received a total of $3,024 in payments from pharmaceutical and medical device companies, with $595.14 received in 2024. These payments were reported across 173 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,012).
As a Medicare-enrolled provider, Chatha has provided services to 864 Medicare beneficiaries, totaling 1,338 services with total Medicare billing of $83,415. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location East Orange, NJ
- Active Since 05/13/2010
- Last Updated 08/03/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1407174451
Products in Payments
- FARXIGA (Drug) $584.35
- Ozempic (Drug) $296.82
- JANUVIA (Drug) $207.15
- Rybelsus (Drug) $140.55
- TEPEZZA (Drug) $124.99
- WATCHMAN (Device) $120.30
- JARDIANCE (Drug) $112.85
- LifeVest (Device) $98.13
- CHANTIX (Drug) $92.60
- TRELEGY ELLIPTA (Drug) $91.88
- ELIQUIS (Drug) $77.25
- Cologuard Collection Kit (Device) $73.53
- Otezla (Drug) $67.38
- Victoza (Drug) $61.36
- XARELTO (Drug) $61.18
- ENTRESTO (Drug) $60.54
- Prolia (Biological) $60.36
- TRULICITY (Drug) $55.16
- LEQVIO (Drug) $40.46
- Aimovig (Biological) $40.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in East Orange
Dr. Alexander Salerno, Md, MD
Internal Medicine — Payments: $73,770
Internal Medicine $73,770
Dr. Gitendra Rajiyah, Md, MD
Internal Medicine — Payments: $20,111
Internal Medicine $20,111
Eddy Simon, Md, MD
Internal Medicine — Payments: $7,943
Internal Medicine $7,943
Dr. Anand Srinivasan, Md, MD
Internal Medicine — Payments: $7,905
Internal Medicine $7,905
Dr. Radhika Maddali, Md, MD
Internal Medicine — Payments: $6,737
Internal Medicine $6,737
Dr. Mamatha Mohan, M.d, M.D
Internal Medicine — Payments: $6,050
Internal Medicine $6,050